Skip to main content
Top

Familial Cancer

Issue 1/2022

Content (14 Articles)

Nevi Short Communication

Atypical choroidal nevus in a subject with a germline PALB2 pathogenic variant

Timothy W. Grosel, Matthew Karl, Robert T. Pilarski, Frederick H. Davidorf, Mohamed H. Abdel-Rahman, Colleen M. Cebulla

Open Access Original Article

Interpretation of BRCA2 Splicing Variants: A Case Series of Challenging Variant Interpretations and the Importance of Functional RNA Analysis

Paola Nix, Erin Mundt, Bradford Coffee, Elizabeth Goossen, Bryan M. Warf, Krystal Brown, Karla Bowles, Benjamin Roa

Salpingo-Oophorectomy Original Article

The needs of Southeast Asian BRCA mutation carriers considering risk-reducing salpingo-oophorectomy: a qualitative study

Hamizah Sa’at, Yew-Kong Lee, Sook-Yee Yoon, Siu Wan Wong, Yin Ling Woo, Kristine Barlow-Stewart, Nur Aishah Mohd Taib

Ovarian Cancer Original Article

Knowledge and psychosocial impact of genetic counseling and multigene panel testing among individuals with ovarian cancer

Rachel A. Pozzar, Fangxin Hong, Niya Xiong, Jill E. Stopfer, Manan M. Nayak, Meghan Underhill-Blazey

Ovarian Cancer Original Article

Comparison of universal screening in major lynch-associated tumors: a systematic review of literature

George Kunnackal John, Vipin Das Villgran, Christine Caufield-Noll, Francis M. Giardiello

Fibromatosis Original Article

Approach to screening for Familial Adenomatous Polyposis (FAP) in a cohort of 226 patients with Desmoid-type Fibromatosis (DF): experience of a specialist center in the UK

E. Cojocaru, S. Gennatas, K. Thway, C. Fisher, A. Smrke, D. Strauss, A. Hayes, M. Smith, R. L. Jones, C. Benson, T. P. McVeigh

Managing gastric cancer risk in lynch syndrome: controversies and recommendations

C. Richard Boland, Matthew B. Yurgelun, Kathryn A. Mraz, Patrick M. Boland

Open Access Original Article

Use of sanger and next-generation sequencing to screen for mosaic and intronic APC variants in unexplained colorectal polyposis patients

Fadwa A. Elsayed, Carli M. J. Tops, Maartje Nielsen, Hans Morreau, Frederik J. Hes, Tom van Wezel

Open Access Short Communication

Infantile fibrosarcoma with TPM3-NTRK1 fusion in a boy with Bloom syndrome

Sue M. Huson, Timo Staab, Marta Pereira, Heather Ward, Roberto Paredes, D. Gareth Evans, Daniel Baumhoer, James O’Sullivan, Ed Cheesman, Detlev Schindler, Stefan Meyer

Correction

Correction to: Infantile fibrosarcoma with TPN3-NTRK3 fusion in a boy with Bloom Syndrome

Sue M. Huson, Timo Staab, Marta Pereira, Heather Ward, Roberto Paredes, D. Gareth Evans, Daniel Baumhoer, James O’Sullivan, Ed Cheesman, Detlev Schindler, Stefan Meyer

Carcinoid Tumor Original Article

Genetic evaluation of patients and families with concern for hereditary endocrine tumor syndromes

Jennifer L. Anderson, Robert Pilarski, Lawrence Kirschner, Pamela Brock

Barrett Esophagus Short Communication

Age of diagnosis in familial Barrett’s associated neoplasia

Benita K. Glamour, Omar Alaber, Gino Cioffi, Apoorva K. Chandar, Jill Barnholtz-Sloan, Wendy Brock, Gary W. Falk, Marcia I. Canto, Jean S. Wang, Prasad G. Iyer, Nicholas J. Shaheen, William M. Grady, Julian A. Abrams, Prashanthi N. Thota, Amitabh Chak, Andrew E. Blum

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine